Abstracts tagged "Musculoskeletal"

Abstract Number: 1053 • ACR Convergence 2021
Temporal Trends and Geographic Variations of Premature Mortality Related to Musculoskeletal(MSK) and Connective Tissue Disorders in the United States: A 20-Year Analysis from WONDER Database
Ikwinder Kaur¹, Mohsin Mughal², Hasan Mirza³, Harjot Jagdey⁴, Pankaj Bansal⁵, Eugenio Capitle⁶ and Fawad Aslam⁷, ¹Monmouth Medical Center, an affiliate of Rutgers health system, Long Branch, NJ, ²Monmouth Medical Center, Long Branch, NJ, ³Berkshire Medical Center, Pittsfield, MA, ⁴BronxCare Hospital, Bronx, NY, ⁵Mayo Clinic Health System, Eau Claire, WI, ⁶Rutgers New Jersey Medical School, New Brunswick, NJ, ⁷Mayo Clinic College of Medicine, Scottsdale, AZ
Background/Purpose: Musculoskeletal system and connective tissue disorders (arthropathies, systemic connective tissue disorders, soft tissue disorders) may contribute to premature mortality likely due to associated comorbidities…
Abstract Number: 1820 • ACR Convergence 2021
Efficacy of Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Musculoskeletal Manifestations of Active PsA in a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Philip Mease¹, Atul Deodhar², Désirée van der Heijde³, Frank Behrens⁴, Alan Kivitz⁵, Tom Lehman⁶, Lan Wei⁶, Marleen Nys⁷, Subhashis Banerjee⁶ and Miroslawa Nowak⁶, ¹Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, ²Oregon Health & Science University, Portland, OR, ³Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, ⁴CIRI/Rheumatology and Fraunhofer Institute, Translational Medicine and Pharmacology ITMP, Goethe University, Frankfurt, Germany, ⁵Altoona Center for Clinical Research, Duncansville, PA, ⁶Bristol Myers Squibb, Princeton, NJ, ⁷Bristol Myers Squibb, Braine-l'Alleud, Belgium
Background/Purpose: Tyrosine kinase 2 (TYK2) is an intracellular kinase that mediates IL-23, IL-12, and IFNα/β signaling. Deucravacitinib is a novel, oral selective inhibitor of TYK2…
Abstract Number: 2212 • 2019 ACR/ARP Annual Meeting
Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA
Dalit Ashany¹, Susan Goodman ², Haley Tornberg ¹, Donald McMahon ³, Douglas Mintz ⁴, Linda Russell ⁵ and Emily Stein ¹, ¹Hospital for Special Surgery, New York, NY, ²Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, ³Donald J.McMahon Statistical Consulting, South Nyack, NY, ⁴Hospital for Special Surgery, Division of Radiology and Imaging, New York, ⁵Hospital for Special Surgery, New York
Background/Purpose: Axial Spondyloarthritis (axSpA) is characterized by abnormal bone formation that produces syndesmophytes, while paradoxically, inflammation causes increased bone resorption and skeletal fragility. Detection of…
Abstract Number: 185 • 2018 ACR/ARHP Annual Meeting
Evaluating Medical Student Confidence and Performance of the Pediatric Musculoskeletal Exam
Kimberly Hays¹, Natasha M. Ruth¹, Donna Kern², Paul J. Nietert³, Lutfiyya Muhammad³, Michele Knoll Friesinger⁴ and Patricia McBurney⁵, ¹Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, ²Family Medicine, Senior Associate Dean for Education, Medical University of South Carolina, Charleston, SC, ³Public Health Sciences, Medical University of South Carolina, Charleston, SC, ⁴Psychiatry and Behavioral Sciences, Assistant Dean for Assessment, Evaluation and Quality Improvement, Medical University of South Carolina, Charleston, SC, ⁵Pediatrics, Medical University of South Carolina, Charleston, SC
Background/Purpose: Children commonly present with musculoskeletal complaints to primary care providers who work in a busy practice with diverse populations. Musculoskeletal complaints may result from…
Abstract Number: 188 • 2018 ACR/ARHP Annual Meeting
Pediatric Trainee Confidence and Exposure to Rheumatology
Jessica Rutsky¹, Ann Salvator², Laura Ballenger³, Steven Cuff⁴ and Kyla Driest⁵, ¹Pediatrics, Nationwide Children's Hospital, Columbus, OH, ²Statistics, Nationwide Children's Hospital, Columbus, OH, ³Department of Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁴Sports Medicine, Nationwide Children's Hospital, Columbus, OH, ⁵Rheumatology, Nationwide Children's Hospital, Columbus, OH
Background/Purpose: A small number of previous studies show residents have low levels of confidence in rheumatologic and musculoskeletal (MSK) skills. The objective of this study…
Abstract Number: 399 • 2018 ACR/ARHP Annual Meeting
Musculoskeletal Comorbidities after Total Knee Replacement for Osteoarthritis
MaryAnn Zhang¹, Faith Selzer², Elena Losina¹, Jamie E. Collins³ and Jeffrey N. Katz¹, ¹Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopedic Surgery, Brigham & Women's Hospital, Boston, MA, ²Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Department of Orthopedic Surgery, Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA
Background/Purpose: For patients undergoing total knee replacement (TKR) for osteoarthritis (OA), preoperative musculoskeletal (MSK) complaints in areas beyond the index knee are common; however, the…
Abstract Number: 345 • 2017 ACR/ARHP Annual Meeting
The Patient Experience of Musculoskeletal Imaging Tests for Investigation of Inflammatory Arthritis: A Mixed Methods Study
Sandra Bourke^1,2, Nicola Dalbeth¹, William J. Taylor³, Anthony Doyle¹ and Merryn Gott¹, ¹University of Auckland, Auckland, New Zealand, ²Auckland district health board, Auckland, New Zealand, ³University of Otago, Wellington, New Zealand
Background/Purpose: Musculoskeletal (MSK) imaging is widely used in rheumatology for diagnosis and management of arthritis. Although the technical and performance properties of MSK imaging tests…
Abstract Number: 2050 • 2017 ACR/ARHP Annual Meeting
Analysis of Data Collected from Right and Left Limbs: Accounting for Dependence and Improving Statistical Efficiency in Musculoskeletal Research
Sarah Stewart¹, Janet Pearson², Keith Rome³, Nicola Dalbeth⁴ and Alain Vandal⁵, ¹School of Podiatry, Auckland University of Technology, Auckland, New Zealand, ²Auckland University of Technology, Auckland, Niger, ³School of Clinical Sceince, Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, ⁴University of Auckland, Auckland, New Zealand, ⁵Counties Manukau District Health Board, Auckland, New Zealand
Background/Purpose: Statistical techniques used in musculoskeletal research often inefficiently account for paired-limb measurements or the relationship between measurements taken from multiple sites within limbs. This…
Abstract Number: 2418 • 2017 ACR/ARHP Annual Meeting
Tissue-Engineered Human Skeletal Muscle Model of Rheumatoid Arthritis
Catherine E. Oliver¹, Brittany N. Davis¹, James Hong¹, Kim M. Huffman² and George A. Truskey³, ¹Duke University, Durham, NC, ²School of Medicine, Division of Rheumatology, Immunology and Molecular Physiology and Durham VA Medical Center, Duke University, Durham, NC, ³BME, Duke University, Durham, NC
Background/Purpose: In rheumatoid arthritis (RA) reduced muscle function clearly contributes to disability. Due to a lack of accurate in vitro RA models, the underlying mechanisms…
Abstract Number: 69 • 2017 ACR/ARHP Annual Meeting
The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models
Tomoyuki Mukai¹, Takafumi Mito¹, Shunichi Fujita¹, Shoko Kodama¹, Akiko Nagasu¹, Teruki Sone², Shinichiro Nishimatsu³, Yutaka Ohsawa⁴, Yoshihide Sunada⁴ and Yoshitaka Morita¹, ¹Department of Rheumatology, Kawasaki Medical School, Kurashiki, Okayama, Japan, ²Department of Nuclear Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan, ³Department of Natural Sciences, Kawasaki Medical School, Kurashiki, Okayama, Japan, ⁴Department of Neurology, Kawasaki Medical School, Kurashiki, Okayama, Japan
Background/Purpose: Myostatin, also called as growth differentiation factor-8 (GDF-8), is a secreted member of TGF-β superfamily. Myostatin is a negative regulator of skeletal muscle mass…
Abstract Number: 157 • 2017 ACR/ARHP Annual Meeting
A Systematic Review of the Upper Limb Soft Tissue Comorbidities in Patients with Type 2 Diabetes Mellitus
Michelle C Papandony¹, Anita E Wluka², Ar Kar Aung³, Yuanyuan Wang¹, Sultana Monira Hussain⁴ and Flavia M Cicuttini¹, ¹Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia, ²Australia, Armadale, Australia, ³Department of General Medicine, Alfred Health, Melbourne, Australia, ⁴Monash University, Department of Epidemiology and Preventative Medicine, Melbourne, Australia
Background/Purpose: Soft tissue disorders affecting the upper limb are not commonly thought of as “classic” complications of type 2 diabetes mellitus. However, the majority of…
Abstract Number: 105 • 2016 ACR/ARHP Annual Meeting
Regional Primary Care Rheumatology Networks for Patients with Rheumatic and Musculoskeletal Diseases: Need for a National Approach
Wilfred Peter¹, Florus van der Giesen², Cornelia H.M. van den Ende³, Joost Dekker⁴ and Thea P. M. Vliet Vlieland⁵, ¹Orthopeadics, Rehabilitation and Physical Therapy, Leids University Medical Center, Leiden, Netherlands, ²Orthopaedics, Rehabilitations and Physical Therapy, Leiden University Medical Centre, Leiden, Netherlands, ³Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ⁴Rehabilitation Medicine, VU University Medical Center, Amsterdam, Netherlands, ⁵Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Regional primary care rheumatology networks of health professionals (HPs) are instituted to improve the quality of care for patients with rheumatic and musculoskeletal diseases…
Abstract Number: 1341 • 2016 ACR/ARHP Annual Meeting
Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Literature Review
Laura Cappelli¹, Anna Kristina Gutierrez², Ami A. Shah³ and Clifton Bingham III⁴, ¹Medicine/Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Johns Hopkins University, Baltimore, MD
Rheumatic and Musculoskeletal Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: A Systematic Literature Review Background/Purpose: Immune checkpoint inhibitors (ICI) are effective treatments for advanced…
Abstract Number: 1187 • 2015 ACR/ARHP Annual Meeting
Comprehensive Musculoskeletal Exam Curriculum for Rheumatology Fellows
Sonali Narain, Shanthini Kasturi and VP Bykerk, Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: The musculoskeletal exam (MSKE) is an integral part of rheumatology training, both as a diagnostic aid, and as a predictor of disease activity. Formal…
Abstract Number: 2261 • 2015 ACR/ARHP Annual Meeting
Association Between Musculoskeletal Pain, Fat Mass and Fat Free Mass: Results from a Population-Based Study
Tiffany K. Gill¹, Tom P. Walsh^2,3, E. Michael Shanahan⁴ and Catherine Hill^5,6, ¹Medicine, The University of Adelaide, Adelaide, Australia, ²Medicine, Flinders University, Adelaide, Australia, ³Podiatry, Repatriation General Hospital, Adelaide, Australia, ⁴Flinders University, Adelaide, Australia, ⁵The Health Observatory, The University of Adelaide, Adelaide, Australia, ⁶Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia
Background/Purpose: Musculoskeletal pain has been shown to commonly occur at multiple sites. This is likely to have a greater impact on abilities to undertake activities…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].